1[1]Eichhorn E J,Grayburn P A.β-Blocker improvement in diastolic performance:The yin and yang of ventricular function changes.Am Heart J,2000,139:584-586.
2[2]Kitzman D W.Heart failure with normal systolic function.Clin Geriatr Med,2000,16(3):489-512.
3[3]Pinamnonti B,di Lenarda A,Sinagra G.Heart failure due to diastolic dysfunction:The treatment principles.Ital Heart J,2000,1(4 Suppl):469-480.
4[4]Zile M R,Nappi J.Diastolic heart failure.Curr Treat Options Cardiovasc Med,2000,2(5):439-450.
5[5]Mandinov L,Eberli F R,Seiler C,et al.Diastolic heart failure.Cardiovasc Res,2000,45:813-825.
6[6]Brown L,Duce B,Mitic G,et al.Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.J Am Soc Nephrol,1999,11(5):S143-148.
7[7]Brilla C G,Funck R C,Rupp H.Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.Circulation,2000,102(12):1342-1345.
8[8]Warner J G Jr,Metzger D C,Kitzman D W,et al.Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise.J Am Coll Cardiol,1999,33(6):1567-1572.
9[9]Sun Y,Weber K T.Infarct scar:A dynamic tissue.Cardiovasc Res,2000,46(2):250-256.
10[10]Verdecchia P,Schillaci G,Reboldi G P,et al.Long-term effects of losartan and enalapril,allone or with a diuretic on ambulatory blood pressure and cardiac performance in hypertension:A case-control study.Blood Press Monit,2000,5(3):187-193.
